News

17 Nov 2014

All our cells have membranes that separate the cell content from the external environment. Thirty percent of human proteins exert their action in these and other cell membranes.

14 Nov 2014

This year the Institute for Research in Biomedicine (IRB Barcelona) is once again participating in Science Week in Catalonia (

13 Nov 2014

The liver stores excess glucose, sugar, in the form of glycogen—chains of glucose—, which is later released to cover body energy requirements.

6 Nov 2014

On Friday 7 and Saturday 8 November, 15 teachers from secondary schools in Catalonia will have the opportunity to get up to date with the latest research in cancer, metastasis and personalized medi

Media mentions

26 Nov 2014

Teresa Tarragó, “More importance is still given to publishing in Nature than setting up a spin-off”.

La Vanguardia

Interview with Teresa Tarragó, co-founder together with Ernest Giralt of the spin-off Iproteos, about the discovery of new drugs for diseases that affect the central nervous system.

Edit link:
17 Nov 2014

Bee and scorpion venom to make drugs

Ara

Extensive article published in Sunday’s issue of ARA on the research line developed by Meritxell Teixidó in Ernest Giralt’s lab to extract natural poison from bees, scorpions and spiders, which provides peptides able to cross the blood-brain barrier. Many drugs cannot enter the brain because of this barrier, which serves to protect this organ against infections.

Edit link:
17 Nov 2014

Science on the verge of unravelling the atomic structures of proteins

ABC

Coverage in the media of the 25th Barcelona BioMed Conference on membrane proteins—molecules that account for 30% of the human genome. To date, the atomic structures of only 3% of these proteins are known from an estimated 15,000.

Edit link:

Photo gallery

Contact

Sònia Armengou
Media Relations Officer
Tel: +34 93 40 37255

Quick facts about IRB

Quick facts

IRB Barcelona is home to nearly 450 research, technical and support staff from 35 countries who share the common goal of contributing to the advancement of the biomedical sciences through investigator–driven research, and improving quality of life by applying advances in this field.

The convergence of biology, chemistry, and structural and computational biology is unique at IRB Barcelona and opens a strategic window to gain insight into basic molecular processes in health and disease.

Research is conducted by 23 groups organized into 5 interdisciplinary programmes. Each programme includes a diverse faculty of researchers with overlapping scientific interests. The research areas have been structured to be highly interactive, fostering multidisciplinarity by combining modern molecular biology, classical genetics, biochemistry, structural biology, bioinformatics, systems biology, advanced microscopy, and genomic and proteomic approaches.

Our Board of Trustees comprises members of the Catalan Government (from the Department of Economy and Competitivity and the Department of Health), the University of Barcelona, a representative from the BBVA Foundation as well as internationally renowned scientists.

IRB Barcelona is housed within the Barcelona Science Park on the University of Barcelona Pedralbes Campus. It is an integral part of the ‘Bioregion of Catalonia’, a rich landscape of research centres of excellence, universities, science parks, hospitals, scientific infrastructures and pharmaceutical companies, all with a focus on the life sciences. It is a member of the CERCA network of government research centres.